SCHEMBL14103743

SCHEMBL14103743

Fc1ccc(-c2nc(Cl)c3sccc3n2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 3/20 0.40
▸ AXL P30530 1/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.39
▸ MKNK2 Q9HBH9 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ CTDSP1 Q9GZU7 2/20 0.39
▸ GLA P06280 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPT P10636 1/20 0.37
▸ CSNK2A1 P68400 2/20 0.36
▸ ATM Q13315 1/20 0.35
▸ MAOA P21397 5/20 0.34
▸ MAOB P27338 5/20 0.34
▸ AR P10275 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ADORA2A P29274 2/20 0.33
▸ ADORA1 P30542 2/20 0.33
▸ PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13789442 0.88 AXL (0.39) PRKCIAXLMKNK1MKNK2NPC1
SCHEMBL13789321 0.88 AXL (0.39) PRKCIAXLMKNK1MKNK2NPC1
SCHEMBL13789438 0.85 AXL (0.41) PRKCIAXLMKNK1MKNK2NPC1
SCHEMBL14103877 0.84 PRKCI (0.39) PRKCINPC1RAB9ANPSR1CTDSP1
SCHEMBL4518564 0.82 AXL (0.39) PRKCIAXLMKNK1MKNK2NPC1
SCHEMBL13789405 0.82 AXL (0.41) PRKCIAXLMKNK1MKNK2NPC1
SCHEMBL13789316 0.78 MAPT (0.50) PRKCIAXLMKNK1MKNK2NPC1
SCHEMBL13789359 0.77 AXL (0.39) PRKCIAXLMKNK1MKNK2NPC1
SCHEMBL14103871 0.77 PIK3CA (0.42) AXLMKNK1MKNK2NPC1RAB9A
SCHEMBL13789312 0.76 AXL (0.41) PRKCIAXLMKNK1MKNK2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008092861-A1 BICYCLIC DERIVATIVES AS EP4 AGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-07 — — WO disclosed
Send feedback